Tests pharmacogénétiques : bientôt avant chaque prescription ? : Prescription Médicamenteuse = Pharmacogenetic testing : soon before every prescription ?BUCLIN, Thierry; COLOMBO, Sara; BIOLLAZ, Jérome et al.Revue médicale suisse. 2008, Vol 4, Num 165, pp 1666-1670, issn 1660-9379, 5 p.Article

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionDI IULIO, Julia; FAYET, Aurélie; EAP, Chin B et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 4, pp 300-309, issn 1744-6872, 10 p.Article

The HCP5 Single-Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to AbacavirCOLOMBO, Sara; RAUCH, Andri; TELENTI, Amalio et al.The Journal of infectious diseases. 2008, Vol 198, Num 6, pp 864-867, issn 0022-1899, 4 p.Article

Determination of Unbound Antiretroviral Drug Concentrations by a Modified Ultrafiltration Method Reveals High Variability in the Free FractionFAYET, Aurélie; BEGUIN, Alexandre; DECOSTERD, Laurent A et al.Therapeutic drug monitoring. 2008, Vol 30, Num 4, pp 511-522, issn 0163-4356, 12 p.Article

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1MARTIN, Maureen P; YING QI; GOEDERT, James J et al.Nature genetics. 2007, Vol 39, Num 6, pp 735-742, issn 1061-4036, 8 p.Article

A whole-genome association study of major determinants for host control of HIV-1FELLAY, Jacques; SHIANNA, Kevin V; COZZI-LEPRI, Alessandro et al.Science (Washington, D.C.). 2007, Vol 317, Num 5840, pp 944-947, issn 0036-8075, 4 p.Article

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort StudyLUBOMIROV, Rubin; COLOMBO, Sara; FURRER, Hansjakob et al.The Journal of infectious diseases. 2011, Vol 203, Num 2, pp 246-257, issn 0022-1899, 12 p.Article

Ritonavir-boosted atazanavir-lopinavir combination : a pharmacokinetic interaction study of total, unbound plasma and cellular exposuresCOLOMBO, Sara; BUCLIN, Thierry; CAVOSSINI, Matthias et al.Antiviral therapy (London). 2006, Vol 11, Num 1, pp 53-62, issn 1359-6535, 10 p.Article

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavirLUBOMIROV, Rubin; DI IULIO, Julia; LEDERGERBER, Bruno et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 4, pp 217-230, issn 1744-6872, 14 p.Article

Orosomucoid (α₁-acid glycoprotein) plasma concentration and genetic variants : Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulationCOLOMBO, Sara; BUCLIN, Thierry; DECOSTERD, Laurent A et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 4, pp 307-318, issn 0009-9236, 12 p.Article

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infectionCOLOMBO, Sara; BUCLIN, Thierry; CAVASSINI, Matthias et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 11, pp 3801-3808, issn 0066-4804, 8 p.Article

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivoCOLOMBO, Sara; SORANZO, Nicole; ROTGER, Margalida et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 9, pp 599-608, issn 1744-6872, 10 p.Article

Impact of Phenotype Definition on Genome-Wide Association Signals: Empirical Evaluation in Human Immunodeficiency Virus Type 1 InfectionEVANGELOU, Evangelos; FELLAY, Jacques; COLOMBO, Sara et al.American journal of epidemiology. 2011, Vol 173, Num 11, pp 1336-1342, issn 0002-9262, 7 p.Article

Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?COLOMBO, Sara; TELENTI, Amalio; BUCLIN, Thierry et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 332-338, issn 0163-4356, 7 p.Article

Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensivesGRANDI, Anna M; SANTILLO, Rosa; BERTOLINI, Andrea et al.American journal of hypertension. 2001, Vol 14, Num 7, pp 644-648, issn 0895-7061, 1Article

Left ventricular changes in isolated office hypertension: A blood pressure-matched comparison with normotension and sustained hypertension. EditorialGRANDI, Anna M; BROGGI, Roberta; COLOMBO, Sara et al.Archives of internal medicine (1960). 2001, Vol 161, Num 22, pp 2655-2656, issn 0003-9926, 7 p.Article

HIV-1 elite controllers: Beware of super-infectionsCLERC, Olivier; COLOMBO, Sara; YERLY, Sabine et al.Journal of clinical virology. 2010, Vol 47, Num 4, pp 376-378, issn 1386-6532, 3 p.Article

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive PersonsROTGER, Margalida; GLASS, Tracy R; RAUCH, Andri et al.Clinical infectious diseases. 2013, Vol 57, Num 1, pp 112-121, issn 1058-4838, 10 p.Article

Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetrationFAYET MELLO, Aurélie; BUCLIN, Thierry; FRANC, Claudia et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 7, pp 1573-1581, issn 0305-7453, 9 p.Article

Does tenofovir influence efavirenz pharmacokinetics?ROTGER, Margalida; COLOMBO, Sara; FURRER, Hansjakob et al.Antiviral therapy (London). 2007, Vol 12, Num 1, pp 115-118, issn 1359-6535, 4 p.Article

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patientsROTGER, Margalida; COLOMBO, Sara; FURRER, Hansjakob et al.Pharmacogenetics (London). 2005, Vol 15, Num 1, pp 1-5, issn 0960-314X, 5 p.Article

Seamless multimedia sessions and real-time measurements in hybrid 3G and WLAN networksDAGIUKLAS, Tasos; POLITIS, Christos; SALLOUM, Fadi-Sotiris et al.International journal of wireless and mobile computing (Print). 2007, Vol 2, Num 2-3, pp 159-172, issn 1741-1084, 14 p.Article